BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Trichostatin A
,
rs7903146
,
DNMT1
,
Leukemia
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dec 205 receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Bone Marrow Dendritic Cells exposed to different antigen delivery systems
Prostate cancer PC-3 cells overexpressing miR-205, AGO2 bound RNAs
T-cells with FOXP3 siRNA knockdown and activated with anti-CD2/CD3/CD28 antibodies + IL2
Effect of IL-17 on human vascular smooth muscle cells
Splenic B cells from Ptger4-/- mice treated with anti-IgM (Fab')2 fragments and PGE2
Explore Curated Studies Results
Literature
Most Relevant Literature
DEC-205 receptor targeted poly(lactic-co-glycolic acid) nanoparticles containing Eucommia ulmoides p…
The cryo-EM structure of the endocytic receptor DEC-205.
Development and characterization of DEC-205 receptor targeted Potentilla anserina L polysaccharide P…
Interaction of human dendritic cell receptor DEC205/CD205 with keratins.
DEC-205 receptor-mediated long-circling nanoliposome as an antigen and Eucommia ulmoides polysacchar…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DCVax Plus Poly ICLC in Healthy Volunteers
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patie…
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced …
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ